EBSCO Logo
Connecting you to content on EBSCOhost
Results
Title

A Small Molecule Targeting the Intracellular Tyrosine Kinase Domain of ROR1 (KAN0441571C) Induced Significant Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells.

Authors

Ghaderi, Amineh; Okhovat, Mohammad-Ali; Lehto, Jemina; De Petris, Luigi; Manouchehri Doulabi, Ehsan; Kokhaei, Parviz; Zhong, Wen; Rassidakis, Georgios Z.; Drakos, Elias; Moshfegh, Ali; Schultz, Johan; Olin, Thomas; Österborg, Anders; Mellstedt, Håkan; Hojjat-Farsangi, Mohammad

Abstract

The ROR1 receptor tyrosine kinase is expressed in embryonic tissues but is absent in normal adult tissues. ROR1 is of importance in oncogenesis and is overexpressed in several cancers, such as NSCLC. In this study, we evaluated ROR1 expression in NSCLC patients (N = 287) and the cytotoxic effects of a small molecule ROR1 inhibitor (KAN0441571C) in NSCLC cell lines. ROR1 expression in tumor cells was more frequent in non-squamous (87%) than in squamous (57%) carcinomas patients, while 21% of neuroendocrine tumors expressed ROR1 (p = 0.0001). A significantly higher proportion of p53 negative patients in the ROR1+ group than in the p53 positive non-squamous NSCLC patients (p = 0.03) was noted. KAN0441571C dephosphorylated ROR1 and induced apoptosis (Annexin V/PI) in a time- and dose-dependent manner in five ROR1+ NSCLC cell lines and was superior compared to erlotinib (EGFR inhibitor). Apoptosis was confirmed by the downregulation of MCL-1 and BCL-2, as well as PARP and caspase 3 cleavage. The non-canonical Wnt pathway was involved. The combination of KAN0441571C and erlotinib showed a synergistic apoptotic effect. KAN0441571C also inhibited proliferative (cell cycle analyses, colony formation assay) and migratory (scratch wound healing assay) functions. Targeting NSCLC cells by a combination of ROR1 and EGFR inhibitors may represent a novel promising approach for the treatment of NSCLC patients.

Subjects

NON-small-cell lung carcinoma; SMALL molecules; PROTEIN-tyrosine kinases; FETAL tissues; APOPTOSIS

Publication

Pharmaceutics, 2023, Vol 15, Issue 4, p1148

ISSN

1999-4923

Publication type

Academic Journal

DOI

10.3390/pharmaceutics15041148

EBSCO Connect | Privacy policy | Terms of use | Copyright | Manage my cookies
Journals | Subjects | Sitemap
© 2025 EBSCO Industries, Inc. All rights reserved